人工智能胃镜检查辅助系统用于早期胃癌筛查的成本和效益分析
作者:
作者单位:

1.武汉大学人民医院;2.武汉大学人民医院消化内科

作者简介:

通讯作者:

中图分类号:

基金项目:

中央高校基本科研业务费专项资金资助(204202kf0084);湖北卫健委创新项目(WJ202C003)


Cost‑effectiveness of early gastric cancer screening using an artificial intelligence gastroscopy‑assisted system
Author:
Affiliation:

Renmin hospital of Wuhan university

Fund Project:

Fundamental Research Fund for the Central Universities (204202kf0084); Innovation Project of Health Commission of Hubei Province (WJ202C003)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 文章评论
    摘要:

    目的 比较使用人工智能(artificial intelligence, AI)胃镜检查辅助系统行胃早期癌筛查前后的成本和效益。方法 回顾性收集2017年1月1日—2022年2月28日于武汉大学人民医院使用AI胃镜辅助系统前后的胃镜检查病例,统计使用前(无AI组)和使用后(AI组)的胃癌早期诊断率。以武汉大学人民医院收费标准和湖北省武汉市按疾病诊断相关分组付费支付标准2021年版本为参考进行费用估算。计算每10万例使用和不使用该系统两种情况下进行胃镜筛查的成本和效益及增量成本效益比。结果 无AI组胃癌早期诊断率为28.81%(70/243),每10万例胃镜筛查成本为5 459.80万元,胃早期癌医疗成本为22.18万元,总成本为5 481.98万元;直接筛查效益为89.42万元,间接筛查效益为182.82万元,总效益为272.24万元。AI组胃癌早期诊断率为36.56%(366/1 001),每10万例胃镜筛查成本为5 344.00万元,胃早期癌医疗成本为31.58万元,总成本为5 375.58万元;直接筛查效益为127.35万元,间接筛查效益为260.31万元,总效益为387.66万元。使用该系统可以降低总成本106.40万元/10万例,多产生115.42万元/10万例的直接和间接经济效益,增量成本效益比为-0.92。结论 使用AI胃镜检查辅助系统进行胃早期癌筛查可以在降低医疗成本的同时提高筛查效益,建议在胃镜筛查工作中推广使用。

    Abstract:

    Objective To compare the cost-effectiveness before and after using an artificial intelligence gastroscopy-assisted system for early gastric cancer screening. Methods The gastroscopy cases before (non-AI group) and after (AI group) the use of artificial intelligence gastroscopy-assisted system were retrospectively collected in Renmin Hospital of Wuhan University from January 1, 2017 to February 28, 2022. The proportion of early gastric cancer among all gastric cancer was analyzed. Costs were estimated based on the standards of Renmin Hospital of Wuhan University and the 2021 edition of Wuhan Disease Diagnosis-related Group Payment Standards. Cost-effectiveness analysis was conducted per 100 thousand cases with and without the system. And the incremental cost-effectiveness ratio was calculated. Results For the non-AI group, the proportion of early gastric cancer among all gastric cancer was 28.81% (70/243). The cost of gastroscopy screening per 100 thousand was 54 598.0 thousand yuan, early gastric treatment cost was 221.8 thousand yuan, and a total cost was 54 819.8 thousand yuan. The direct effectiveness was 894.2 thousand yuan, the indirect effectiveness was 1 828.2 thousand yuan and the total effectiveness was 2 722.4 thousand yuan per 100 thousand cases. For the AI group, the early gastric cancer diagnositic rate was 36.56%(366/1 001), where gastroscopy cost was 53 440.0 thousand yuan, early gastric treatment cost 315.8 thousand yuan, the total cost 53 755.8 thousand yuan. The direct effectiveness was 1 273.5 thousand yuan, indirect effectiveness 2 603.1 thousand yuan and the total effectiveness 3 876.6 thousand yuan per 100 thousand cases. The use of the system reduced the cost of early gastric cancer screening by 1 064.0 thousand yuan, and increased the benefit by 1 154.2 thousand yuan per 100 thousand cases. The incremental cost-effectiveness ratio was -0.92. Conclusion The use of artificial intelligence gastroscopy-assisted system for gastric early cancer screening can reduce medical costs as well as improve the efficiency of screening, and it is recommended for gastroscopy screening.

    参考文献
    相似文献
    引证文献
引用本文

黄丽,吴练练,朱益洁,等.人工智能胃镜检查辅助系统用于早期胃癌筛查的成本和效益分析[J].中华消化内镜杂志,2023,40(12):1001-1005.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-04-24
  • 最后修改日期:2023-12-18
  • 录用日期:2022-07-01
  • 在线发布日期: 2024-01-02
  • 出版日期:
您是第位访问者

通信地址:南京市鼓楼区紫竹林3号《中华消化内镜杂志》编辑部   邮编:210003

中华消化内镜杂志 ® 2024 版权所有
技术支持:北京勤云科技发展有限公司